Assessment of risk factors for candidemia in non-neutropenic patients hospitalized in Internal Medicine wards: A multicenter study

European Journal of Internal Medicine

Volumn 41, Issue , 2017, Pages 33-38

  Falcone, M ^a   Tiseo, G ^a   Tascini, C ^b   Russo, A ^a   Sozio, E ^b   Raponi, G ^a   Rosin, C ^d   Pignatelli, P ^a   Carfagna, P ^c   Farcomeni, A ^a   Luzzati, R ^d   Violi, F ^a   Menichetti, F ^b   Venditti, M ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY HOSPITAL OF PISA   (Italy)

^c SAN GIOVANNI ADDOLORATA HOSPITAL   (Italy)

^d UNIVERSITY HOSPITAL OF TRIESTE   (Italy)

Author keywords

Candidemia; Clostridium difficile infection; Internal Medicine; Non neutropenic patients; Risk factors; Sepsis

Indexed keywords

GLYCOPEPTIDE; ANTIFUNGAL AGENT;

AGED; ANTIBIOTIC THERAPY; AREA UNDER THE CURVE; ARTICLE; CANDIDEMIA; CARDIOLOGY; CASE CONTROL STUDY; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GENERAL PRACTICE; HOSPITAL INFECTION; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTERNAL MEDICINE; ITALY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEPHROLOGY; NEUTROPENIA; PEPTOCLOSTRIDIUM DIFFICILE; PERIPHERALLY INSERTED CENTRAL VENOUS CATHETER; PULMONOLOGY; RHEUMATOLOGY; RISK ASSESSMENT; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SEPTIC SHOCK; TOTAL PARENTERAL NUTRITION; WARD; CANDIDA; CLINICAL TRIAL; CROSS INFECTION; HOSPITAL; MICROBIOLOGY; RETROSPECTIVE STUDY; STATISTICAL MODEL; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANTIFUNGAL AGENTS; CANDIDA; CANDIDEMIA; CASE-CONTROL STUDIES; CROSS INFECTION; FEMALE; HOSPITALIZATION; HOSPITALS; HUMANS; INTERNAL MEDICINE; ITALY; LOGISTIC MODELS; MALE; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 85019893884     PISSN: 09536205     EISSN: 18790828     Source Type: Journal    
DOI: 10.1016/j.ejim.2017.03.005     Document Type: Article

References (35)

1. Wisplinghoff, H., Bischoff, T., Tallent, S.M., Seifert, H., Wenzel, R.P., Edmond, M.B., Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 39 (2004), 309–317.
2. Puig-Asensio, M., Padilla, B., Garnacho-Montero, J., Zaragoza, O., Aguado, J.M., Zaragoza, R., et al. Epidemiology and predictive factors for early and late mortality in Candida bloodstream infections: a population-based surveillance in Spain. Clin Microbiol Infect 20 (2014), O245–O254.
3. Puig-Asensio, M., Ruiz-Camps, I., Fernández-Ruiz, M., Aguado, J.M., Muñoz, P., Valerio, M., et al. Epidemiology and outcome of candidaemia in patients with oncological and haematological malignancies: results from a population-based surveillance in Spain. Clin Microbiol Infect, 21, 2015 (491.e1-10).
4. Bassetti, M., Mikulska, M., Viscoli, C., Bench-to-bedside review: therapeutic management of invasive candidiasis in the intensive care unit. Crit Care, 14, 2010, 244.
5. Pappas, P.G., Kauffman, C.A., Andes, D., Benjamin, D.K. Jr., Calandra, T.F., Edwards, J.E. Jr., et al. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 48 (2009), 503–535.
6. Bassetti, M., Taramasso, L., Nicco, E., Molinari, M.P., Mussap, M., Viscoli, C., Epidemiology, species distribution, antifungal susceptibility and outcome of nosocomial candidemia in a tertiary care hospital in Italy. PLoS One, 6, 2011, e24198.
7. Milazzo, L., Peri, A.M., Mazzali, C., Grande, R., Cazzani, C., Ricaboni, D., et al. Candidaemia observed at a university hospital in Milan (northern Italy) and review of published studies from 2010 to 2014. Mycopathologia 178 (2014), 227–241.
8. De Rosa, F.G., Corcione, S., Filippini, C., Raviolo, S., Fossati, L., Montrucchio, C., et al. The effect on mortality of fluconazole or echinocandins treatment in candidemia in internal medicine wards. PLoS One, 10, 2015, e0125149.
9. Bassetti, M., Molinari, M.P., Mussap, M., Viscoli, C., Righi, E., Candidaemia in internal medicine departments: the burden of a rising problem. Clin Microbiol Infect 19 (2013), E281–E284.
10. Bassetti, M., Merelli, M., Righi, E., Diaz-Martin, A., Rosello, E.M., Luzzati, R., et al. Epidemiology, species distribution, antifungal susceptibility, and outcome of candidemia across five sites in Italy and Spain. J Clin Microbiol 51 (2013), 4167–4172.
11. Hii, I.M., Chang, H.L., Lin, L.C., Lee, Y.L., Liu, Y.M., Liu, C.E., et al. Changing epidemiology of candidemia in a medical center in middle Taiwan. J Microbiol Immunol Infect 48 (2015), 306–315.
12. Kim, S.H., Yoon, Y.K., Kim, M.J., Sohn, J.W., Clinical impact of time to positivity for Candida species on mortality in patients with candidaemia. J Antimicrob Chemother 68 (2013), 2890–2897.
13. Falcone, M., Russo, A., Iraci, F., Carfagna, P., Goldoni, P., Vullo, V., et al. Risk factors and outcomes for bloodstream infections secondary to Clostridium difficile infection. Antimicrob Agents Chemother 60 (2015), 252–257.
14. Freifeld, A.G., Bow, E.J., Sepkowitz, K.A., Boeckh, M.J., Ito, J.I., Mullen, C.A., et al. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of america. Clin Infect Dis 52 (2011), e56–e93.
15. Luzzati, R., Cavinato, S., Giangreco, M., Granà, G., Centonze, S., Deiana, M.L., et al. Peripheral and total parenteral nutrition as the strongest risk factors for nosocomial candidemia in elderly patients: a matched case-control study. Mycoses 56 (2013), 664–671.
16. Dellinger, R.P., Levy, M.M., Rhodes, A., Annane, D., Gerlach, H., Opal, S.M., et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med 39 (2013), 165–228.
17. Rodriguez-Alvarez, M.X., Roca-Pardinas, J., Cadarso-Suarez, C., A new flexible direct ROC regression model - application to the detection of cardiovascular risk factors by anthropometric measures. Comput Stat Data Anal 55 (2011), 3257–3270.
18. Pepe, M.S., Fan, J., Seymour, C.W., Estimating the receiver operating characteristic curve in studies that match controls to cases on covariates. Acad Radiol 20 (2013), 863–873.
19. Kullberg, B.J., Arendrup, M.C., Invasive candidiasis. N Engl J Med 373 (2016), 1445–1456.
20. Luzzati, R., Cavinato, S., Deiana, M.L., Rosin, C., Maurel, C., Borelli, M., Epidemiology and outcome of nosocomial candidemia in elderly patients admitted prevalently in medical wards. Aging Clin Exp Res 27 (2015), 131–137.
21. Ostrosky-Zeichner, L., Clinical prediction rules for invasive candidiasis in the ICU: ready for prime time?. Crit Care, 15, 2011, 189.
22. Sutton, P.A., Li, S., Webb, J., Solomon, K., Brazier, J., Mahida, Y.R., Essential role of toxin A in C. difficile 027 and reference strain supernatant-mediated disruption of Caco-2 intestinal epithelial barrier function. Clin Exp Immunol 153 (2008), 439–447.
23. De Rosa, F.G., Corcione, S., Pagani, N., Di Perri, G., From ESKAPE to ESCAPE, from KPC to CCC. Clin Infect Dis 60 (2015), 1289–1290.
24. De Rosa, F.G., Corcione, S., Raviolo, S., Montrucchio, C., Aldieri, C., Pagani, N., et al. Candidemia, and infections by Clostridium difficile and carbapenemase-producing Enterobacteriaceae: new enteropathogenetic opportunistic syndromes?. Infez Med 23 (2015), 105–116.
25. Guastalegname, M., Russo, A., Falcone, M., Giuliano, S., Venditti, M., Candidemia subsequent to severe infection due to Clostridium difficile: is there a link?. Clin Infect Dis 57 (2013), 772–774.
26. Russo, A., Falcone, M., Fantoni, M., Murri, R., Masucci, L., Carfagna, P., et al. Risk factors and clinical outcomes of candidaemia in patients treated for Clostridium difficile infection. Clin Microbiol Infect 21 (2015), 493.e1–493.e4.
27. Zaoutis, T.E., Prasad, P.A., Localio, A.R., Coffin, S.E., Bell, L.M., Walsh, T.J., et al. Risk factors and predictors for candidemia in pediatric intensive care unit patients: implications for prevention. Clin Infect Dis 51 (2010), e38–e45.
28. Liu, M., Huang, S., Guo, L., Li, H., Wang, F., Zhang, Q.I., et al. Clinical features and risk factors for blood stream infections of Candida in neonates. Exp Ther Med 10 (2015), 1139–1144.
29. Samonis, G., Maraki, S., Barbounakis, E., Leventakos, K., Lamaris, G., Rovithi, M., et al. Effects of vancomycin, teicoplanin, linezolid, quinupristin-dalfopristin, and telithromycin on murine gut colonization by Candida albicans. Med Mycol 44 (2006), 193–196.
30. Chopra, V., O'Horo, J.C., Rogers, M.A., Maki, D.G., Safdar, N., The risk of bloodstream infection associated with peripherally inserted central catheters compared with central venous catheters in adults: a systematic review and meta-analysis. Infect Control Hosp Epidemiol 34 (2013), 908–918.
31. Advani, S., Reich, N.G., Sengupta, A., Gosey, L., Milstone, A.M., Central line-associated bloodstream infection in hospitalized children with peripherally inserted central venous catheters: extending risk analyses outside the intensive care unit. Clin Infect Dis 52 (2011), 1108–1115.
32. Tascini, C., Sozio, E., Tintori, G., Ripoli, A., Sbrana, F., Rosselli Del Turco, E., et al. Peripherally inserted central catheter as a predominant risk factor for candidemia in critically ill patients in internal medicine wards in Italy. Intensive Care Med 41 (2015), 1498–1499.
33. Tascini, C., Falcone, M., Bassetti, M., De Rosa, F.G., Sozio, E., Russo, A., et al. Candidemia in patients with body temperature below 37 °C and admitted to internal medicine wards: assessment of risk factors. Am J Med 129 (2016), 1330.e1–1330.e6.
34. Kollef, M., Micek, S., Hampton, N., Doherty, J.A., Kumar, A., Septic shock attributed to Candida infection: importance of empiric therapy and source control. Clin Infect Dis 54 (2012), 1739–1746.
35. Bassetti, M., Righi, E., Ansaldi, F., Merelli, M., Trucchi, C., De Pascale, G., et al. A multicenter study of septic shock due to candidemia: outcomes and predictors of mortality. Intensive Care Med 40 (2014), 839–845.